![Stephan Reynier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephan Reynier
Compliance Officer at
CELLECTIS S.A.
Net worth: 113 535 $ as of 31/08/2026
Profile
Stephan Reynier currently works at Cellectis SA, as Chief Regulatory & Compliance Officer from 2011.
Mr. Reynier also formerly worked at Gilead Sciences, Inc., as Associate Medical Affairs Director-European Region from 2002 to 2006, Voisin Consulting, Inc., as Senior Director, Takara Bio Europe AB, as Head-Project Management & Regulatory Affairs, and Ectycell SASU, as Head-Programs from 2011 to 2014.
Mr. Reynier received his graduate degree from the University of Toronto.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CELLECTIS S.A. 0.05% | 15/02/2026 | 33,313 ( 0.05% ) | 113 535 $ | 31/08/2026 |
Stephan Reynier active positions
| Companies | Position | Start |
|---|---|---|
| CELLECTIS S.A. | Compliance Officer | 01/04/2011 |
Former positions of Stephan Reynier
| Companies | Position | End |
|---|---|---|
Ectycell SASU
 Ectycell SASU BiotechnologyHealth Technology Produces and sales stem cells | Corporate Officer/Principal | 01/01/2014 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/06/2006 |
Voisin Consulting, Inc.
 Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides product development consulting services | Director/Board Member | - |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | General Counsel | - |
Training of Stephan Reynier
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
69
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | Commercial Services |
Ectycell SASU
Ectycell SASU BiotechnologyHealth Technology Produces and sales stem cells | Health Technology |
Voisin Consulting, Inc.
Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides product development consulting services | Commercial Services |
- Stock Market
- Insiders
- Stephan Reynier
